You have 9 free searches left this month | for more free features.

Cardiotoxicity of Chemotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chemotherapy-induced Cardiotoxicity.

Recruiting
  • Cardiotoxicity
  • +2 more
  • Blood sampling
  • +4 more
  • Prague, Czechia
  • +1 more
Aug 15, 2023

Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • São Paulo, Brazil
    Instituto do Coração
Aug 16, 2023

Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)

Active, not recruiting
  • Breast Cancer
  • +4 more
  • Rozzano, Milan, Italy
    IRCCS Humanitas Research Hospital
Feb 5, 2023

Chemo-induced Cardiotoxicity, Breast Cancer Trial in Tanta (Rosuvastatin 20mg)

Recruiting
  • Chemotherapy-induced Cardiotoxicity
  • Breast Cancer
  • Rosuvastatin 20mg
  • Tanta, Egypt
    The Department of Clinical Oncology, Tanta University Hospital
Apr 18, 2022

Developing Cardiotoxicity After Receiving Chemotherapy for

Recruiting
  • Breast Cancer
  • +2 more
  • Cardiac Imaging
  • Data Collection
  • Montréal, Quebec, Canada
  • +2 more
Dec 20, 2022

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Rochester (Echocardiography, Electronic Health Record

Suspended
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Echocardiography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 10, 2023

Cardiotoxicity, Systolic Dysfunction, Exercise, Aerobic Trial in Montevideo (Aerobic exercise (experimental), Flexibility

Recruiting
  • Cardiotoxicity
  • +2 more
  • Aerobic exercise (experimental)
  • Flexibility exercise (active comparator)
  • Montevideo, Uruguay
    Centro Cardiovascular Universitario-Hospital de Clínicas -FMED-
Jul 30, 2022

Atherosclerosis in Chemotherapy-related Cardiotoxicity

Recruiting
  • Cardiotoxicity
  • Atherosclerosis
  • echocardiography, computed tomography
  • Warsaw, Poland
    National Institute of Oncology
Feb 20, 2022

Cardiotoxicity Trial in Warsaw (Empagliflozin 10 MG, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • Empagliflozin 10 MG
  • Placebo
  • Warsaw, Poland
  • +1 more
Mar 5, 2022

Chemotherapy Related Cardiotoxicity

Recruiting
  • Cardiotoxicity
  • Gastrointestinal Neoplasms
    • London, United Kingdom
      St Bartholomews Hospital
    Dec 1, 2021

    Cardiomyopathies, Chemo Effect, Diastolic Dysfunction Trial in Tehran (Bisoprolol, Placebo)

    Completed
    • Cardiomyopathies
    • +3 more
    • Tehran, Iran, Islamic Republic of
      Rasool Akram hospital
    Dec 30, 2021

    TRPC6 to Predict and Prevent Chemotherapy Related Cardiac

    Not yet recruiting
    • Breast Carcinoma
    • Cardiotoxicity
    • Biospecimen Collection
    • Electronic Medical Record
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Aug 17, 2022

    Risk HDS and HCT in Patients With Haemoblasts.

    Recruiting
    • Cardiotoxicity
    • electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan
    • Moscow, Russian Federation
      Sechenov University
    Aug 18, 2022

    Heart Failure Trial in Ottawa (L-carnitine)

    Terminated
    • Heart Failure
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Institute
    Aug 12, 2022

    Participants Undergoing Anthracycline Chemo Trial in Cincinnati (autoRIC®)

    Recruiting
    • Participants Undergoing Anthracycline Chemotherapy
    • autoRIC®
    • Cincinnati, Ohio
      Cincinnati Children's Hospital
    Jun 24, 2022

    New Echocardiographic Indicators in Treatment of Primary

    Not yet recruiting
    • Multiple Myeloma
    • Chemotherapy and/or autologous hematopoietic stem cell transplantation
    • (no location specified)
    Sep 18, 2023

    Cardiotoxicity in Patients Undergoing Chemotherapy.

    Recruiting
    • Cardiotoxicity
    • +2 more
    • Echocardiography with speckle tracking analysis.
    • +2 more
    • Moscow, Moscow Region, Russian Federation
      Moscow State University of Medicine and Dentistry, Department of
    Oct 15, 2021

    Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)

    Recruiting
    • Breast Cancer
    • Non Hodgkin Lymphoma
    • Middlesbrough, Teesside, United Kingdom
      South Tees Hospitals NHS FT
    Oct 20, 2022

    Cardiotoxicity, Acute Myeloid Leukemia in Children, Bone Tumor Trial in Cairo (Capoten®)

    Recruiting
    • Cardiotoxicity
    • +2 more
    • Cairo, Egypt
      Children's Cancer Hospital Egypt 57357 Cairo, Egypt
    Aug 2, 2021

    Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)

    Enrolling by invitation
    • Breast Cancer
    • +4 more
    • Tanta, Egypt
      Tanta university
    Oct 22, 2022

    Serial PET MPI in Patients Undergoing Cancer Treatment

    Enrolling by invitation
    • Cancer
    • +3 more
      • Los Angeles, California
        West Los Angeles VA Medical Center
      Jun 12, 2023

      Cardiotoxicity, Toxicity Due to Chemo, Breast Cancer Trial in Duarte, Philadelphia, West Chester (Biomarker Guided Intervention)

      Recruiting
      • Cardiotoxicity
      • +5 more
      • Biomarker Guided Intervention
      • Duarte, California
      • +2 more
      Jul 29, 2022

      Cancer, Heart Failure, Cardiotoxicity Trial in Toronto (Atorvastatin, Placebo oral tablet)

      Active, not recruiting
      • Cancer
      • +2 more
      • Toronto, Ontario, Canada
        Toronto General Hospital
      Feb 4, 2022

      Cardiotoxicity, Cardiac Rehabilitation Trial in Santiago de Compostela (Cardiac rehabilitation)

      Active, not recruiting
      • Cardiotoxicity
      • Cardiac Rehabilitation
      • Cardiac rehabilitation
      • Santiago de Compostela, A Coruña, Spain
        Hospital Clínico Universitario de Santiago
      May 8, 2021

      Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

      Completed
      • Breast Cancer
      • Cardiac Toxicity
      • trastuzumab
      • +11 more
      • Rochester, Minnesota
        Mayo Clinic Cancer Research Consortium
      Jul 12, 2022